Skip to content

Clinical trials

Phase 3 Glaucoma, Open-Angle trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glaucoma, Open-Angle Phase: Phase 3 Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20021
20032
20044
20059
20063
20073
20086
20096
20108
201113
20122
20132
20146
20156
20166
20173
20186
20198
20204
20216
20225
20232
20242
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109
Recruiting8
Unknown status6
Withdrawn6
Terminated5
Suspended1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research36
Santen Pharmaceutical Co., Ltd.10
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.8
Aerie Pharmaceuticals7
AbbVie6
Allergan6
Glaukos Corporation6
Santen Oy5
Laboratorios Sophia S.A de C.V.3
National Eye Institute (NEI)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glaucoma, Open-Angle137
Ocular Hypertension117
Glaucoma38
Hypertension9
Cataract3
Exfoliation Syndrome1
Glaucoma, Angle-Closure1
Glaucoma, Neovascular1

Trials

Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.